Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus, Adult-Onset”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03258840
What this trial is testing

EPA Supplementation on Vascular Inflammation, and Gene Expression of PON2 in Patients With Type II Diabetes Mellitus

Who this might be right for
Diabetes Mellitus Type II
Tehran University of Medical Sciences 36
Not applicableStudy completedNCT01961024
What this trial is testing

Postprandial VLDL-TG Metabolism

Who this might be right for
Type 2 Diabetes
University of Aarhus 21
Large-scale testing (Phase 3)Study completedNCT01467323
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 303
Testing effectiveness (Phase 2)UnknownNCT01989962
What this trial is testing

E4E-Health Professional Education for Improving Care for Canadian Aboriginal Populations

Who this might be right for
Diabetes Mellitus Type 2Cultural Competency
Queen's University 860
Not applicableStudy completedNCT02266576
What this trial is testing

A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians

Who this might be right for
Diabetes Mellitus, Type 2Metabolic SyndromeInsulin Resistance
Stanford University 207
Not applicableStudy completedNCT02551640
What this trial is testing

Improving Physical Activity Through a mHealth Intervention in Cardio-metabolic Risk Patients

Who this might be right for
Diabetes Mellitus, Type 2Prediabetic StateHypertension+2 more
Massachusetts General Hospital 300
Not applicableStudy completedNCT02761018
What this trial is testing

Using Technology to Share Fitness Goals and Results to Improve Diabetes Outcomes

Who this might be right for
Type II Diabetes Mellitus
Mike O'Callaghan Military Hospital 120
Not applicableUnknownNCT02076880
What this trial is testing

SLEEVEDIAB To Explore the Early and Late Metabolic Effects of Sleeve Gastrectomy in Obese Patients

Who this might be right for
Severe ObesityType 2 Diabetes
University Hospital, Montpellier 14
Testing effectiveness (Phase 2)Study completedNCT03700580
What this trial is testing

Clinical Trial Using the Proteolytic Fraction P1G10 From V. Cundinamarcensis to Heal Diabetic Foot Ulcer

Who this might be right for
Diabetic FootNeuropathy, DiabeticFoot Ulcer
Carlos E Salas 50
Not applicableStudy completedNCT04345497
What this trial is testing

Diabetes-Specific Formula on Long Term Glycemic Control

Who this might be right for
Diabetes Mellitus, Type 2
Abbott Nutrition 251
Not applicableUnknownNCT03082859
What this trial is testing

Acute Exercise and Free-living Glycaemic Control in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Ulster 14
Large-scale testing (Phase 3)WithdrawnNCT04287179
What this trial is testing

SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S
Early research (Phase 1)Study completedNCT04109508
What this trial is testing

A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets

Who this might be right for
Healthy VolunteersType 2 Diabetes
Novo Nordisk A/S 278
Post-approval studies (Phase 4)UnknownNCT01478776
What this trial is testing

The Impact of Omega-3 Supplementation on Gene Expression in Type 2 Diabetics

Who this might be right for
Type 2 Diabetes
Tehran University of Medical Sciences 20
Not applicableStudy completedNCT04710940
What this trial is testing

Development and Feasibility Testing of DM-BOOST Intervention.

Who this might be right for
Diabetes Mellitus, Type 2
Daniel Amante 66
Early research (Phase 1)UnknownNCT01142050
What this trial is testing

Stem Cell Therapy for Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Cellonis Biotechnology Co. Ltd. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT06254274
What this trial is testing

RAY1225 in Participants With Type 2 Diabetes

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Guangdong Raynovent Biotech Co., Ltd 210
Not applicableUnknownNCT04764279
What this trial is testing

A Rural OPTIFAST Intervention for Partial Remission of Type 2 Diabetes in Adults With Obesity

Who this might be right for
Diabetes Mellitus, Type 2Obesity
Marathon Family Health Team 30
Post-approval studies (Phase 4)Study completedNCT00641407
What this trial is testing

Bedtime Insulins and Oral Antihyperglycemic Drugs in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusHypoglycemia
University of Campania Luigi Vanvitelli 100
Early research (Phase 1)Study completedNCT03310944
What this trial is testing

Comparison of Sotagliflozin Prototype Tablets With Reference Tablet in Healthy Subjects

Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes Mellitus
Sanofi 12
Next Page